Venetoclax as a cytoreduction therapy for acute promyelocytic leukaemia: A single-centre experience

Br J Haematol. 2023 Dec;203(5):892-895. doi: 10.1111/bjh.19119. Epub 2023 Sep 20.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
  • Cytoreduction Surgical Procedures
  • Humans
  • Leukemia, Promyelocytic, Acute* / drug therapy
  • Sulfonamides / therapeutic use

Substances

  • venetoclax
  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides